Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
ITI Pharma & Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited16.718619988136.6242
Domestic EquitiesDivi's Laboratories Limited6.23452243713.6574
Domestic EquitiesLupin Limited5.82686091012.7643
Domestic EquitiesMax Healthcare Institute Limited5.336310644511.6898
Domestic EquitiesApollo Hospitals Enterprise Limited5.30871666811.6293
Domestic EquitiesSuven Pharmaceuticals Limited5.196510011111.3836
Domestic EquitiesAurobindo Pharma Limited4.2425756149.2937
Domestic EquitiesTorrent Pharmaceuticals Limited4.1274272179.0415
Domestic EquitiesMankind Pharma Limited3.0637272246.7115
Domestic EquitiesAlkem Laboratories Limited2.9083124536.3710
Domestic EquitiesAster DM Healthcare Limited2.86891244626.2847
Domestic EquitiesFortis Healthcare Limited2.3742758645.2009
Domestic EquitiesAbbott India Limited2.313316905.0675
Domestic EquitiesNeuland Laboratories Limited1.971336014.3183
Domestic EquitiesGranules India Limited1.8237876503.9951
Domestic EquitiesWockhardt Limited1.6841284513.6892
Domestic EquitiesHealthcare Global Enterprises Limited1.6179630133.5442
Domestic EquitiesFDC Limited1.4972779083.2799
Domestic EquitiesSumitomo Chemical India Limited1.3465579942.9496
Domestic EquitiesSupriya Lifescience Limited1.3299451592.9134
Domestic EquitiesOrchid Pharma Limited1.3258362582.9043
Domestic EquitiesRainbow Childrens Medicare Limited1.2709201502.7841
Domestic EquitiesJB Chemicals & Pharmaceuticals Limited1.1938162192.6152
Domestic EquitiesDr. Reddy's Laboratories Limited1.1651215582.5523
Domestic EquitiesCipla Limited1.0911154192.3901
Domestic EquitiesEmcure Pharmaceuticals Limited1.0880233232.3834
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited1.069979062.3438
Domestic EquitiesGland Pharma Limited1.0500164292.3001
Domestic EquitiesCaplin Point Laboratories Limited1.0352120702.2678
Domestic EquitiesVijaya Diagnostic Centre Limited1.0188223082.2319
Domestic EquitiesSRF Limited0.982271512.1517
Domestic EquitiesSequent Scientific Limited0.98131491712.1496
Domestic EquitiesUPL Limited0.9808320722.1485
Domestic EquitiesShilpa Medicare Limited0.9748330042.1355
Domestic EquitiesLaurus Labs Limited0.9653350172.1145
Domestic EquitiesOnesource Specialty Pharma Limited0.9296125272.0363
Domestic EquitiesLinde India Limited0.906731351.9863
Domestic EquitiesSai Life Sciences Limited0.8469266261.8553
Domestic EquitiesStrides Pharma Science Limited0.8168275331.7894
Total 97.4833 213.5492
Cash & Cash Equivalents and Net AssetsTREPS 02-May-20252.6791 5.8690
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.1625 -0.3559
Total 2.5167 5.5131
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.